AdaptHealth Corp. (AHCO)

NASDAQ • Healthcare

$6.06

+$0.2 (+3.6%)

Market closed

Last close at September 11, 2026 at 20:00 UTC

Open$5.95

Day Range$5.87 - $6.1

Avg. Volume (3M)2.7M

Market Cap$824.4M

52 Week Range

$5.21$13.43

Next EarningsIn 51 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q2 2026

Revenueeverything earned$819.7M100%

Gross Profitminus cost of goods$101.3M12%

Operating Incomeminus R&D and overhead$6.8M1%

In plain terms: out of every $100 in revenue, AdaptHealth Corp. currently loses $2.

Fundamentals & Financials

Revenue (TTM)

$3B

Net Income (TTM)

-$228.2M

EPS (TTM)

-$1.68

ROA (TTM)

-5.26%

Current Ratio

1.12

Dividend Yield

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

-93.3%Q3 2025$0.01

-8.3%Q4 2025$0.22

-20.6%Q1 2026$0.27

-580.0%Q2 2026-$0.06

-64.5%Q3 2026$0.06

Nov 3

in 51 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026

Miss -64.5%

AdaptHealth’s preliminary results for the second fiscal quarter of 2026, reported August 4, 2026, missed consensus on both revenue and adjusted EPS even as sales rose sharply year over year. Revenue climbed 25.1% to roughly $740.3 million (up from about $591.8 million a year ago), but it trailed the $846.8 million estimate (-12.6%). Adjusted EPS came in at $0.06 versus $0.17 expected (-64%, trailed), up from $0.01 a year ago. Profitability metrics were mixed: gross profit was about $104.2 million, with gross margin at about 14.1%. On cash generation, the company posted operating cash flow of roughly $145.3 million. For the next period, consensus calls for EPS of -$0.05 on revenue of $725.9 million.

View full earnings history

About AdaptHealth Corp.

AdaptHealth Corp. provides home-based medical equipment and supplies across the United States, with a focus on patients managing ongoing conditions outside institutional settings. The NASDAQ-listed AHCO operates in healthcare through medical devices and related services, and generated $3.2 billion of revenue in FY2025.

Name

AdaptHealth Corp.

CEO

Suzanne Foster

Website

adapthealth.com

Industry

Healthcare

Employees

10,900

Today's Snapshot

AI-generated

AHCO closed 3.6% higher at 6.06, while its sector was flat. Volume was about two-thirds of its usual level.

Trading Volume

Below 10d avg (2.8M)

1.8M

vs S&P 500 Today

Outperforming Market

+2.66%

Updated: September 11, 2026 at 20:12 UTC

Technical Indicators

1 Buy3 Neutral4 Sell

AHCO is graded sell despite some short-term moving averages beneath the price, because the broader trend shows clear weakness: ADX is strong and long-term averages sit well above the current level, signaling dominant downward pressure. Momentum is mixed with neutral RSI and a modest positive short-term impulse, yet volume metrics and ATR indicate above-average volatility and background selling pressure. Classic and Fibonacci pivots sit lower, but they do not offset the overarching trend strength and higher-term moving-average resistance. Technical takeaway: Sell — strong trend and higher-term average resistance outweigh short-term bounces.

All signals